cytos.com

Kuros BioSciences - Home

Innovation in bone healing and tissue repair. Kuros Biosciences AG is a Swiss-based company focused on the development of innovative products for tissue repair and regeneration. Kuros Biosciences obtains European patent covering osteoinductive materials. Kuros announced today that its Dutch subsidiary, Kuros Biosciences BV, has been granted the European patent, EP3021878, entitled Method for producing an osteoinductive calcium phosphate and products thus obtained by the European. READ MORE. Kuros (SIX: K...

http://www.cytos.com/

OVERVIEW OF cytos.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

4

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR CYTOS.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

November

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.1 out of 5 with 10 reviews

5 star

0

4 star

5

3 star

3

2 star

0

1 star

2

Hey there! Start your review of cytos.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

3.2 seconds

FAVICON PREVIEW

16x16
32x32
64x64
128x128
160x160
192x192
256x256

CONTACTS AT CYTOS.COM

Cytos Biotechnology AG

Wagi●●●●. 25

Sch●●●ren , Zurich, 8952

SWITZERLAND

1411●●●●4644

pe●●●●●●●●●●@cytos.com

View this contact

Cytos Biotechnology AG

Cytos Biotechnology AG

Wagi●●●●. 25

Sch●●●ren , Zurich, 8952

SWITZERLAND

1411●●●●4644

ip●●●●●@cytos.com

View this contact

Cytos Biotechnology AG

Services, Cytos IT

Wagis●●●●●se 25

Sch●●●ren , null, 8952

SWITZERLAND

1410●●●●4747

it●●●●●●●@cytos.com

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 1998 April 21
UPDATED: 2014 April 08
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

27

YEARS
1

MONTHS
28

DAYS

NAME SERVERS

1: ns1.cyberlink.ch
2: ns2.cyberlink.ch
3: ns3.cyberlink.ch

REGISTRAR

NETWORK SOLUTIONS, LLC.

WHOIS : whois.networksolutions.com

REFERRED : http://networksolutions.com

CONTENT

PAGES IN
THIS WEBSITE

4

SSL

EXTERNAL LINKS

9

SITE IP

82.165.151.158

LOAD TIME

3.245 sec

SCORE

6.2

PAGE TITLE

Kuros BioSciences - Home | cytos.com Reviews

<META> DESCRIPTION

Innovation in bone healing and tissue repair. Kuros Biosciences AG is a Swiss-based company focused on the development of innovative products for tissue repair and regeneration. Kuros Biosciences obtains European patent covering osteoinductive materials. Kuros announced today that its Dutch subsidiary, Kuros Biosciences BV, has been granted the European patent, EP3021878, entitled Method for producing an osteoinductive calcium phosphate and products thus obtained by the European. READ MORE. Kuros (SIX: K...

<META> KEYWORDS

1 about kuros

2 overview

3 executive committee

4 board

5 careers

6 pipeline

7 orthobiologics

8 fracture repair

9 magnetos

10 spinal fusion

CONTENT

Page content here

KEYWORDS ON PAGE

about kuros,overview,executive committee,board,careers,pipeline,orthobiologics,fracture repair,magnetos,spinal fusion,solitary bone cysts,sealants,neuroseal kur 023,technologies,surface science technology,synthetic cross linking technology,fibrin based

SERVER

Apache

POWERED BY

PleskLin

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Kuros BioSciences - Home | cytos.com Reviews

https://cytos.com

Innovation in bone healing and tissue repair. Kuros Biosciences AG is a Swiss-based company focused on the development of innovative products for tissue repair and regeneration. Kuros Biosciences obtains European patent covering osteoinductive materials. Kuros announced today that its Dutch subsidiary, Kuros Biosciences BV, has been granted the European patent, EP3021878, entitled Method for producing an osteoinductive calcium phosphate and products thus obtained by the European. READ MORE. Kuros (SIX: K...

INTERNAL PAGES

cytos.com

1

Kuros BioSciences - Management

http://www.cytos.com/management

Innovation in bone healing and tissue repair. Didier Cowling - Founder and Chief Executive Officer. Dr Alistair Irvine - Chief Business Officer. Dr Virginia Jamieson - Chief Medical Officer. Virginia worked for Kuros from 2005 until 2012 as Medical Director and then as Chief Medical Officer leading the clinical and regulatory functions. Dr Philippe Saudan - Chief Development Officer. Dr Jason Schense - Founder and Chief Technology Officer. Harry Welten - Chief Financial Officer.

2

Kuros BioSciences - Calendar

http://www.cytos.com/calendar

Innovation in bone healing and tissue repair. Jun 16, 2016. Wagistrasse 25, 8952 Schlieren, Switzerland. Tel: 41 (0)44 200 56 00 Fax: 41 (0)44 200 56 01 Email: info@kuros.ch. Jun 16, 2016.

3

Kuros BioSciences - Board

http://www.cytos.com/board

Innovation in bone healing and tissue repair. Christian Itin - Chairman. Mrs Caron is Executive Vice President and Chief Commercial Officer for AgNovos Healthcare. A healthcare executive for the past 20 years, she developed an acumen in business development, strategic planning and partnerships, global marketing, and overall business management. Mrs Caron received her Pharmacy degree from the University of Toronto and her MBA from Concordia and Cornell Universities.

4

Kuros BioSciences - Collaborations

http://www.cytos.com/collaborations

Innovation in bone healing and tissue repair. Formally known as Oncore). In January 2015 Cytos has exclusively licensed CYT003 in the field of Hepatitis B to Arbutus Pharmaceuticals LLC. In August 2015 Cytos has exclusively licensed CYT003 in the field of Oncology to Checkmate Pharmaceuticals LLC. Wagistrasse 25, 8952 Schlieren, Switzerland. Tel: 41 (0)44 200 56 00 Fax: 41 (0)44 200 56 01 Email: info@kuros.ch. Formally known as Oncore).

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

4

LINKS TO THIS WEBSITE

vectorie.eu

Consortium | Vectorie

http://vectorie.eu/submenuitem

Emerging vector-borne diseases in Europe. Increased risk of disease outbreaks in Europe. Increasing notification of cases. The viruses: WNV and CHIKV. How are WNV and CHIKV transmitted? Vector-borne Risks for Europe. VECTORIE integrates the expertise of eight partners and is coordinated by the Viroscience lab of Erasmus Medical Centre. Under Prof. Ab Osterhaus.The partners combined harbour the necessary expertise and research facilities to conduct the various analyses included in the project.

global-life-science-ventures.com

GLSV - Portfolio Companies

http://www.global-life-science-ventures.com/portfolio/index.html

Global Life Science Ventures — Investing in the life sciences. The first fund started its activities in 1996 and invested in 18 companies. The second fund GLSV II started in 2001 and invested in 18 companies primarily in Europe and the US. After termination of the investment period, the fund exited the remaining assets in 2015 and is in liquidation. Currenty, no new investments are being sought. Agendia B. V. Website: www.agendia.com. Nabriva Therapeutics GmbH,. Is a biopharmaceutical company engaged in ...

global-life-science-ventures.com

GLSV - Latest news & events Archive

http://www.global-life-science-ventures.com/news/portfolionews-archive.html

Global Life Science Ventures — Investing in the life sciences. The first fund started its activities in 1996 and invested in 18 companies. The second fund GLSV II started in 2001 and invested in 18 companies primarily in Europe and the US. After termination of the investment period, the fund exited the remaining assets in 2015 and is in liquidation. Currenty, no new investments are being sought. Portfolio news - Archive. Pieris Pharmaceuticals Announces First Cancer Immunotherapy Collaboration. Pieris Ph...

healthcap.eu

Exited Investments - HealthCap

http://www.healthcap.eu/the-investments/exited-investments

Senior and Special Advisors. The first five funds have financed 91 companies. Approximately 30 of the companies were startups and several have successfully completed their Initial Public Offerings. HealthCap I, II, III, IV and V are now fully invested. The most recent fund, HealthCap VI, was established in the spring of 2011. HealthCap VI is currently actively pursuing new investment opportunities. Acquired by Nektar in 2005). Acquired by Investor in 2014). Acquired by Bayer in 2014). Is developing Ersat...

psteiner.net

Curriculum vitae

http://www.psteiner.net/peter/cv_en.html

Peter Steiner, Ph.D. Born on 21. 08. 1973. In Uznach, Switzerland. November 2004 - today. Head Production and Processes. Member of the Senior Management. Zürich-Schlieren, Switzerland. December 2002 - September 2004. Founder and member of the Management. April 1999 - June 1999. Contract work for Bioprocess development and validation. August 1998 – August 2002. Dissertation at the Institut of Biotechnologie. Mechanisms of acetate resistance in acetic acid bacteria". October 1993 - April 1998. To high acet...

empiricon.ch

Unsere Kunden

https://www.empiricon.ch/ueber-uns/unsere-kunden

Unsere Kunden sind Unternehmen, die ihre Organisation laufend weiterentwickeln. Die nachfolgende Liste zeigt eine Auswahl an Referenzen. Diese Kunden haben mit uns Projekte auf den Gebieten Mitarbeiterbefragung, Kundenumfrage oder Consulting abgeschlossen. Öffentliche Verwaltungen, Behörden, Non-Profit. Website von Baloise Holding. Website von The Body Shop. Website von Bank EKI. Website von Import Parfumerie. Website von Switzerland Global Enterprise. Website von UPK Basel. Website von Kanton Aargau.

pubs.acs.org

C&EN: Latest News - Design Of An Antismoking Pill

http://pubs.acs.org/cen/news/83/i23/8323antismoking.html

Latest News RSS Feed. May 31, 2005. Design Of An Antismoking Pill. The makers of varenicline got their inspiration from two natural products. More than two-thirds of the U.S.’s nearly 50 million smokers want to quit smokingbut only about 5% of those who try actually manage to kick the habit cold turkey, according to estimates from the Centers for Disease Control and Prevention. Rsquo;s Zyban, a drug originally used to treat depression. Nicotine binds these same receptors to trigger dopamine release....

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL LINKS TO THIS WEBSITE

9

OTHER SITES

cytory.de

Cytory

Diagnostiziert und brillant fotografiert von Prof. Dr. H. Flenker.

cytorzoohx3.skyrock.com

cytorzoohx3's blog - Blog de cytorzoohx3 - Skyrock.com

J'texpliique lààh chuiii àà mi (77). 20/01/2011 at 3:44 PM. 20/01/2011 at 10:20 PM. Subscribe to my blog! Don't forget that insults, racism, etc. are forbidden by Skyrock's 'General Terms of Use' and that you can be identified by your IP address (66.160.134.2) if someone makes a complaint. Please enter the sequence of characters in the field below. Posted on Thursday, 20 January 2011 at 8:12 PM. La clacla la Grd klaaasse. Please enter the sequence of characters in the field below. Post to my blog.

cytos-medical-services.de

cytos medical services

Praxis & Personal. Cytos medical services GmbH Webdesign.

cytos.3x.ro

cytos.3x.ro/ nu exista

Http:/ cytos.3x.ro/. Nu exista pe serverul de gazduire gratuita. Cauta in paginile romanesti:. Iata cateva propuneri din reteaua 3x.ro. Site-ul personal alui cytos . diferite lucruri despre mine si despre prietenii mei . CYTOS- - GR SCOLAR "MIHAIL STURDZA" IASI DIFERITE CHESTII DESPRE LICEU SI DESPRE CLASA MEA.

cytos.ch

Home | Cytos

This domain has just been registered for one of our customers! Domain registration and webhosting at best prices.

cytos.com

Kuros BioSciences - Home

Innovation in bone healing and tissue repair. Kuros Biosciences AG is a Swiss-based company focused on the development of innovative products for tissue repair and regeneration. Kuros Biosciences obtains European patent covering osteoinductive materials. Kuros announced today that its Dutch subsidiary, Kuros Biosciences BV, has been granted the European patent, EP3021878, entitled Method for producing an osteoinductive calcium phosphate and products thus obtained by the European. READ MORE. Kuros (SIX: K...

cytos.com.br

:: Laboratório Cytos ::

Consulte aqui seus laudos online e em tempo real. Programa de Incentivo ao Controle de Qualidade da Sociedade Brasileira de Patologia. Clique aqui para conhecer.

cytos.net

Sie sehen hier eine soeben freigeschaltete Homepage

cytos.org

ビーグレンの美白効果　３ヶ月で私のシミはここまで消えた【体験談】

初めはホームページを作るなんてこと、これっぽっちも考えていなかったのでビーグレン使用前使用後のきちんとした写真を撮っていなくてゴメンナサイ。トライアルセットの本体価格は1,800円しかもうれしいことに送料代引き手数料ともに０円でした。美白トライアルセットの化粧水１０ＹＢローション感想.

cytosa.com.au

Welcome | CYTOSA Developments

Cytosa Developments delivers technical and business solutions. To projects and operating businesses. Our capability primarily lies in the energy, process, utilities, marine and coastal infrastructure sectors. With both breadth and depth in engineering, marine science and business management, we offer a diversity of value adding and problem solving solutions to:. Project owners and managers. We work with clients to maximise value and minimise problems through the project and business life cycle:.

cytosafe.com

cytosafe.com - This website is for sale! - cytosafe Resources and Information.

The owner of cytosafe.com. Is offering it for sale for an asking price of 1999 USD! The owner of cytosafe.com. Is offering it for sale for an asking price of 1999 USD! This page provided to the domain owner free. By Sedo's Domain Parking. Disclaimer: Domain owner and Sedo maintain no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo or domain owner and does not constitute or imply its association, endorsement or recommendation.